Spruce Biosciences, Inc.
SPRB
$52.64
$2.875.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.24% | 32.93% | 26.53% | -21.44% | -12.13% |
| Total Depreciation and Amortization | 2,684.38% | 621.62% | -54.35% | -52.83% | -46.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 241.89% | 52.33% | 13.31% | -72.54% | -60.78% |
| Change in Net Operating Assets | 105.53% | 130.98% | 91.55% | 90.06% | 55.81% |
| Cash from Operations | 17.16% | 45.41% | 40.45% | -2.26% | -3.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 23.18% | -1.85% | -26.82% | 0.00% | 0.00% |
| Issuance of Common Stock | 850,414.29% | 75,763.64% | 20,253.66% | -94.39% | -95.38% |
| Repurchase of Common Stock | -260.94% | -244.67% | -237.80% | -1.30% | -1.30% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -65,150.00% | -- | -- | -- |
| Cash from Financing | 6,763.66% | 3,300.89% | 2,780.70% | -18.66% | -18.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 249.93% | 151.25% | 117.63% | -27.46% | -91.73% |